Highlights Johnson & Johnson

Equities

JNJ

US4781601046

Market Closed - Nyse Other stock markets 04:00:02 2024-05-31 pm EDT			After market 07:00:02 pm
146.9 ^USD	+1.09%		148	+0.78%

May. 31	Sector Update: Health Care Stocks Higher Late Afternoon	MT
May. 31	US lawmakers ask FBI for briefing on GenScript Biotech's links to China	RE

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Higher Late Afternoon	May. 31	MT
Sector Update: Health Care Stocks Advance Friday Afternoon	May. 31	MT
Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars	May. 31	MT
J&J: completes acquisition of Shockwave Medical	May. 31	CF
Johnson & Johnson Closes Acquisition of Shockwave Medical	May. 31	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	May. 31	MT
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	May. 30	CI
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	May. 30	MT
J&J: encouraging results in the treatment of depression	May. 29	CF
Johnson & Johnson's Phase 3 Trial of Seltorexant to Treat Major Depressive Disorder Meets Primary, Secondary Endpoints	May. 29	MT
J&J's treatment for depression succeeds in late stage study	May. 29	RE
Johnson & Johnson Announces Pivotal Study of Seltorexant Shows Statistically Significant and Clinically Meaningful Improvement in Depressive Symptoms and Sleep Disturbance Outcomes	May. 29	CI
Sector Update: Health Care Stocks Fall Late Afternoon	May. 28	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	May. 28	MT
Sector Update: Health Care	May. 28	MT
Bio-Thera, Stada Enter Deal for Biosimilar Candidate to Johnson & Johnson's Simponi in EU, UK	May. 28	MT
Johnson & Johnson Agrees to Buy Numab Unit, Investigational Skin Disease Treatment For $1.25 Billion	May. 28	MT
Top Midday Stories: Wall Street Returns to T+1 Settlements; T-Mobile Buys US Cellular's Wireless Ops; Energy Transfer Buys WTG Midstream; GameStop Extends Rally	May. 28	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	May. 28	MT
Johnson & Johnson to Acquire Experimental Eczema Drug for $1.25 Billion	May. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 12:30 pm EST